Alzheimer’s Research From Memory Care Experts
More than five million Americans are affected by Alzheimer’s disease, and every 66 seconds someone in the U.S. develops the disease. Without a breakthrough cure, that number could more than triple to 16 million by 2050.
These statistics make it understandable that those involved in the care of Alzheimer’s disease and other forms of memory loss, including capital providers, investors and operators, are curious about what the future holds for memory care. What will happen to demand for care over the next three to five years? Is the existing supply of care too much or inadequate? Does the future include more buildings designed for people with dementia but also new approaches to care?
Recent Alzheimer’s and dementia research findings could provide some answers. These findings will be discussed during a National Investment Center (NIC) panel discussion, titled, The Future Demand for Alzheimer’s Care: What Current Research Reveals, on September 26-28, 2017, at the Sheraton Grand Chicago.
The discussion will be moderated by Enlivant’s CEO, Jack Callison, and will feature leading Alzheimer’s experts, including:
Maria Carrillo, the chief science officer at the Alzheimer’s Association, who also oversees the World Wide Alzheimer’s Disease Neuroimaging Initiative, a multi-country research effort aimed at finding the bio-markers for the early detection of the disease.
Dr. Pinchas Cohen, dean of the Davis School of Gerontology at the University of Southern California, who will share the latest non-pharmacological behavioral research findings that focus on environmental, cognitive and lifestyle decisions that impact the manifestations of the disease.
Jean Makesh, CEO and founder of the Lantern Group, an assisted living and memory care provider, who has designed and implemented highly innovative memory care approaches that are being used successfully throughout his senior living communities, such as a virtual time capsule that facilitates memory and promotes functional independence.
“The session will hopefully spark intellectual curiosity and provide additional insight from leading experts outside of our industry in order to think about what this means for the next decade and plan accordingly,” said Callison. “Industry stakeholders need to understand where the research is headed.”
While reserving what the dementia research findings may mean for the future of Alzheimer’s care for the panel discussion, Callison hints that what attendees could hear from panelists may be viewed by some as provocative.
“The session may very well challenge and disrupt the way we think about Alzheimer’s disease and what it means for future demand,” said Callison. “These experts may challenge conventional wisdom and our previously held beliefs.”
Registration for the 2017 NIC Fall Conference is open. Register now.